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ABSTRACT 
MiR-429 functions as a tumor suppressor and has been observed in multiple types of cancer, but the effects and 
mechanisms of miR-429 in osteosarcoma are poorly understood. This study is performed to evaluate the functions 
of miR-429 in the progression of osteosarcoma. Firstly, the miR-429 expression in osteosarcoma tissues and oste-
osarcoma cells was detected using real time PCR, and the relationship between miR-429 expression and overall 
survival of osteosarcoma was analyzed. Secondly, the effects of miR-429 on the migration, invasion, proliferation 
and apoptosis of osteosarcoma cells were evaluated using transwell assay, wound-healing assay, CCK-8 assay and 
flow cytometry, respectively. Proteins related to epithelial-mesenchymal transition (EMT), E-cadherin, Vimentin, 
N-cadherin and Snail, were also detected using Western blot. Finally, the target gene of miR-429 in osteosarcoma 
was predicted and verified using dual luciferase assay and the expression correlation between them was analyzed 
using Pearson’s correlation. MiR-429 was down-regulated in osteosarcoma tissues and osteosarcoma cells; the 
expression level of miR-429 was associated with the prognosis of osteosarcoma. High level of miR-429 in osteo-
sarcoma cells significantly suppressed the migration, invasion and proliferation of cells but induced cells apopto-
sis. Furthermore, high level of miR-429 in osteosarcoma cells obviously increased the expression of E-cadherin 
protein but decreased the expression of Vimentin, N-Cadherin and Snail proteins. EMT inducer ZEB1 was the 
target gene of miR-429 and the expression of ZEB1 was negatively related to the miR-429 expression in osteosar-
coma. In conclusion, miR-429 may functions as a tumor suppressor and be down-regulated in osteosarcoma. MiR-
429 may suppress the progression and metastasis of osteosarcoma by down-regulating the ZEB1 expression.  
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INTRODUCTION 
MicroRNA, a small non-coding RNA, its 
differential expression is related to time 
phase, cell type and tissue (Lagos-Quintana et 
al., 2002; Wienholds et al., 2005). MiRNAs 
can regulate gene expression at a posttran-
scriptional level via base-pairing with 
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mRNAs of target genes, a certain miRNA 
may regulate different genes’ expression and 
a certain gene mRNA may be regulated by 
multiple miRNAs (Friedman et al., 2009; 
Krek et al., 2005). The target genes express 
proteins involved in different biological pro-
cesses of cell functions, so miRNAs play mul-
tiple roles in many biological processes and 
animal development (Brennecke et al., 2003; 
Chen et al., 2004; Cuellar and McManus, 
2005). Similarly, the development of disease 
is also associated with aberrant miRNA ex-
pression in organism, like inherited diseases 
(Mencia et al., 2009), heart disease (Thum et 
al., 2007). In addition, plenty of miRNAs also 
have been determined to link with cancer. 
Over-expression of miR-155 down-regulates 
DNA mismatch repair protein MLH1 and 
may cause colon cancer (Valeri et al., 2010). 
Deficiency of miR-324a may be related to the 
poor survival of NSCLC (Vosa et al., 2011). 
Down-regulation of miR-30a is associated 
with epithelial-to mesenchymal transition 
(EMT) in non-small cell lung cancer 
(Kumarswamy et al., 2012). 
Accumulating researches have been deter-
mined to focus on the roles of miR-429 in tu-
morigenesis, which is a member of miR-200 
family. Members of miR-200 family are 
down-regulated during EMT in normal mu-
rine mammary epithelial cells (NmuMG) 
(Korpal et al., 2008). miR-429 expression is 
negatively correlated with the colorectal can-
cer progression and overexpression of miR-
429 may suppress cell apoptosis, while the tu-
mor inhibiting effect of miR-429 in colorectal 
carcinoma may function via targeting One-
cut2 (Li et al., 2013; Sun et al., 2014). miR-
429 functions as a tumor suppressor by down-
regulating the expression of transcriptional 
repressor ZEB1 in oral squamous cell carci-
noma and breast cancer (Lei et al., 2015; Ye 
et al., 2015), while suppresses invasion and 
promotes apoptosis through targeting Bcl-2 
and SP1 in esophageal carcinoma (Wang et 
al., 2013). These studies suggest that miR-429 
may play important roles in multiple tumor 
diseases via regulating different target genes’ 
expression. 
Osteosarcoma (OS) is one of the most 
common primary tumors, and commonly 
formed in the bones of arms and legs of chil-
dren and adolescents. OS is apt to metastasis 
and recurrence with low survival rate 
(Ottaviani and Jaffe, 2009). But there is few 
evidence to determine the functions of miR-
429 in OS progression (Liu et al., 2014). To 
verify the effects of miR-429 in the tumor-
igenesis of OS, the expression level of miR-
429 in OS tissues and OS cell lines was deter-
mined, furthermore, the effects of miR-429 
overexpression on OS cells’ invasion, metas-
tasis, proliferation, apoptosis and EMT were 
evaluated. In addition, target gene predication 
and verification of miR-429 and the correla-
tion analysis were also performed. 
 
MATERIAL AND METHODS 
Clinical specimens 
A total of 50 OS tissue and 20 non-cancer-
ous bone tissues were obtained from 50 pa-
tients with osteosarcoma who underwent sur-
gery at Yongchuan Hospital of Chongqing 
Medical University from June 2008 to July 
2011. Those patients who received chemo- or 
radiotherapy before surgery were excluded 
and OS tissues were confirmed using patho-
logical method. All patients were followed up 
regularly after surgery until January 2014 (5 
years) or until death. This study has been ap-
proved by the Ethics Committee of 
Yongchuan Hospital of Chongqing Medical 
University (Chongqing, China) and each pa-
tient has given the written informed consent. 
 
Cell culture and transfection 
Human fetal osteoblastic cell line 1.19 
(hFOB 1.19) and OS cell lines (Saos2 and 
U2OS) were purchased from ATCC (Ameri-
can Type Culture Colleciton) and cultured in 
DMEM (Gibco, Los Angeles, USA) supple-
mented with 10 % FBS (Hy-Clone, Logan, 
USA) at 37 ºC in a humidified atmosphere 
with 5 % CO2. HEK-293T cells were cultured 
in DMEM supplemented with 10 % FBS and 
prepared for dual luciferase assay. Saos2 cells 
and U2OS cells were transfected with mimics 
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NC or miR-429 mimics according to the in-
struction of Lipofectamine 2000 (Invitrogen, 
Carlsbad, USA) respectively, and EMT mark-
ers were detected using Western blot 48 h 
post-transfection. Furthermore, Saos2 cells 
and U2OS cells were transfected with mimics 
NC or miR-429 mimics or inhibitor NC or 
miR-429 inhibitor respectively for expression 
detection of ZEB1 mRNA and protein. Mim-
ics NC, miR-429 mimics, inhibitor NC and 
miR-429 inhibitor were purchased from 
GenePharma (Shanghai, China). 
 
Transwell invasion assay 
24-well Transwell insert chambers (8-μm 
pore size, Corning, USA) pretreated with 
Matrigel (BD Biosciences) were used for in-
vasion assay. 4 ×104 cells (Saos2 or U2OS) 
transfected with mimics NC or miR-429 mim-
ics were seeded in each upper well with free-
serum medium, and the lower chamber well 
was filled with DMEM supplemented with 
10 % FBS. After 24 h incubation at 37 ºC in a 
humidified atmosphere with 5 % CO2, cells 
invaded through the Matrigel to the lower sur-
face of filter were fixed with 4 % paraformal-
dehyde followed by staining with 0.1 % crys-
tal violet and imaged under microscope. The 
experiments were performed three times inde-
pendently. 
 
Wound-healing assay 
Cellular migration ability was determined 
using wound-healing assay. Mimics NC- or 
miR-429 mimics-transfected OS cells (Saos2 
or U2OS) were seeded into each well of 12-
well plates and made a straight line wound 
with a pipette tip when cell layers reached 
confluence. Then cells were washed with PBS 
and cultured in serum-free medium for 24 h. 
The closure of the wounds in each well was 
evaluated using an inverted microscopy. The 
experiments were performed three times inde-
pendently. 
 
Cell viability assay 
CCK8 assay was used to evaluate cell vi-
ability. Saos2 or U2OS cells (5×103 cells) 
transfected with mimics NC or miR-429 mim-
ics were seeded in each well of 96-well plates. 
CCK8 solution (10 μl) (Beyotime, Jiangsu, 
China) was added to each well after incuba-
tion for 24 h, 48 h and 72 h, respectively, and 
further incubated for 1 h. Absorbance of each 
well at 450 nm was measured on a microplate 
reader. The experiments were performed 
three times independently. 
 
Cell apoptosis assay 
Annexin V-FITC Apoptosis Detection Kit 
(Beyotime) and flow cytometry were used to 
determine cell apoptosis. 5×104 cells were 
suspended with 195 μl Annexin V-FITC bind-
ing buffer after 48 h transfection followed by 
adding 5 μl Annexin V-FITC and 10 μl PI 
staining solution and further incubated for 
10 min at room temperature in the dark. Cell 
apoptosis was detected using flow cytometry 
with CellQuest software. The experiments 
were performed three times independently. 
 
Dual luciferase assays 
The pmirGLO vector was purchased from 
Promega (Madison, USA) and used for dual 
luciferase assay. The target sequence of miR-
429 in the 3’-UTR region of ZEB1 was pre-
dicted using Targetscan software. 3’-UTR se-
quence of ZEB1 mRNA including predicted 
miR-429 binding site and 3’-UTR sequence 
with corresponding mutation were ligated 
into the pmirGLO vector, respectively. And 
HEK-293T cells, seeded in a 24-well plate 
with 1×105 cells per well, were cotransfected 
with 500 ng pmirGLO-ZEB1 3’-UTR wt or 
pmirGLO-ZEB1 3’-UTR mut and 15 pmol 
mimics NC or miR-429 mimics or inhibitor 
NC or miR-429 inhibitor using Lipofectamine 
2000 (Invitrogen), respectively. Each group 
was treated with three duplications. After 48 
h of incubation, the luciferase activities were 
detected by Dual Luciferase Reporter Assay 
System (Promega).  
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Quantitative real-time PCR 
Total RNA was extracted from OS tissues 
or OS cells using Trizol reagent (Invitrogen) 
to analyze the miR-429 expression or ZEB1 
mRNA expression. The miR-429 level was 
quantified by the TaqMan miRNA Assay 
(Life Technologies, Grand Island, USA) and 
7900 Real-Time PCR System (Applied Bio-
systems, Foster City, USA) according to the 
instructions, U6 expression level was detected 
as internal normalized reference. The primers 
used for amplification of miR-429 and U6 
were purchased from Applied Biosystems. 
The detection of ZEB1 mRNA level was per-
formed using PrimeScript RT reagent Kit and 
SYBR Premix Ex Taq (Takara, Dalian, 
China), GAPDH mRNA level was detected as 
internal normalized reference. Primers for 
ZEB1 and GAPDH were as follow: ZEB1 pri-
mers (forward, 5′-TTAGTTGCTCCCTGTG-
CAGTT-3′ and reverse, 5′-TAGGAGCCAG-
AATGGGAAAAG-3′), GAPDH primers 
(forward, 5’-ACGGGAAGCTCACTGGCA-
TGG-3’ and reverse, 5’-GGTCCACCACCC-
TGTTGCTGTA-3’). 
 
Western blot 
Total protein was extracted from OS cells 
using RIPA buffer (Beyotime, Shanghai, 
China) and quantified using BCA assay kit 
(Bio-rad, China) as per the manufacture’s in-
struction. Then total protein (40 μg) from 
each sample was separated using SDS-PAGE 
and transferred to a PVDF membrane. The 
membranes were probed with anti-E-cadherin 
antibody (Abcam, ab76055), anti-Vimentin 
antibody (Abcam, ab8978), anti-N-Cadherin 
antibody (Abcam, ab98952), anti-Snail anti-
body (Abcam, ab117866), anti-ZEB1 anti-
body (Abcam, ab181451) and anti-β-actin an-
tibody (Abcam, ab8224) after blocked with 
5 % non-fat milk. Then the membranes were 
further probed with HRP-conjugated second 
antibody (Abcam, ab6728). β-actin was used 
as an internal control and protein bland was 
detected with enhanced chemiluminescence 
(Amersham Pharmacia). Densitometry of 
Western blots was quantified using NIH Im-
ageJ software (Bethesda, USA). Blotting im-
ages and densitometry results were repre-
sentative from 3 repeats. 
 
Statistical analysis 
Kaplan-Meier method was used to plot the 
survival curves based on miR-429 relative ex-
pression and overall survival, statistical sig-
nificance was determined by the log-rank test. 
Continuous data were presented as mean ± 
SD and analyzed using GraphPad Prism 5 
software, comparison between groups was 
performed by an independent t test, P value 
less than 0.05 was considered statistically sig-
nificant. Correlation analysis between miR-
429 relative expression and ZEB1 relative ex-
pression in OS tissues was performed using 
Pearson’s correlation. 
 
RESULTS  
MiR-429 down-regulates in OS tissues and 
cells, OS patients with high level of miR-
429 had better prognosis 
MiR-429 level in OS tissues and OS cells 
was detected by real time PCR and compared 
with that in normal tissues and hFOB cells. 
The results showed that miR-429 level in OS 
tissues and OS cells were significantly higher 
than that in normal tissues and hFOB cells (P 
< 0.01) (Figure 1A, B). Furthermore, patients 
with osteosarcoma were divided into two 
groups, high miR-429 expression group and 
low miR-429 expression group, to analyze the 
relationship between overall survival of pa-
tients with osteosarcoma and miR-429 ex-
pression using Kaplan-Meier survival analy-
sis. High level of miR-429 was associated 
with high overall survival rate for patients 
with osteosarcoma (P = 0.0215) (Figure 1C). 
These results indicate that miR-429 was 
down-regulated in OS tissues and cells and re-
lated to the prognosis of OS patients. 
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Figure 1: The clinicopathological features of miR-429 expression in osteosarcoma. 
A: The detection of miR-429 expression in osteosarcoma tissues using real time PCR. B: The detection 
of miR-429 expression in osteosarcoma cell lines using real time PCR, ** P < 0.01 vs hFOB 1.19 cells. 
C: The survival curves based on miR-429 relative expression and overall survival was plotted using 
Kaplan-Meier method.  
 
 
 
 
Overexpression of miR-429 suppresses the 
invasion, metastasis, proliferation and  
promotes apoptosis of OS cells in vitro 
The functions of miR-429 in OS cells 
were evaluated on the basis of transwell inva-
sion assay, wound-healing assay, CCK-8 pro-
liferation assay and cellular apoptosis assay. 
The results of transwell invasion assay 
showed that invasive ability of OS cells 
(Saos2, U2OS) transfected with miR-429 
mimics was decreased obviously than that of 
cells transfected with mimics NC (Figure 
2A). This was consistent with the results of 
wound-healing assay (P < 0.01) (Figure 2B). 
The proliferative capability of OS cells was 
detected at 24 h, 48 h and 72 h after transfec-
tion with miR-429 mimics or mimics NC, re-
spectively. The results showed that the prolif-
erative capability of OS cells transfected with 
miR-429 mimics was attenuated compared 
with that of cells transfected with mimics NC, 
and the difference was more apparent at 48 h 
and 72 h (P < 0.01) (Figure 2C and 2D). 
Apoptosis portion of OS cells transfected with 
miR-429 was significantly lower than that of 
cells transfected with mimics NC (P < 0.01) 
(Figure 2E). These results suggest that high 
level of miR-429 may function as a suppres-
sor miR in OS cells and inhibits the invasion, 
metastasis, proliferation of OS cells but in-
duces OS cells’ apoptosis. 
 
Overexpression of miR-429 up-regulates E-
cadherin protein expression and down-reg-
ulates the protein expression of Vimentin, 
N-cadherin and Snail in OS cells  
To evaluate the effects of miR-429 on ep-
ithelial-mesenchymal transition (EMT), pro-
teins related to EMT, such as E-cadherin, Vi-
mentin, N-cadherin and Snail, were detected 
using Western blot and the relative optical 
density was analyzed too. Whether in Saos2 
cells or U2OS cells, the protein level of E-
cadherin was raised obviously whereas pro-
tein levels of Vimentin, N-cadherin and Snail 
were all dramatically declined when cells 
were transfected with miR-429 mimics (P < 
0.01) (Figure 3), indicating that high level of 
miR-429 may depress EMT of OS cells.  
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Figure 2: Function verification of miR-429 in osteosarcoma cells. 
A: Invasive ability of osteosarcoma cells with high level of miR-429 was significantly attenuated com-
pared with that of cells in control group. B: Migration ability of osteosarcoma cells with high level of miR-
429 was evaluated using wound-healing assay, ** P < 0.01. C: Proliferation of osteosarcoma cells with 
high level of miR-429 was evaluated within 72 h using CCK-8 assay, * P < 0.01, ** P < 0.01. D: Cell 
apoptosis of osteosarcoma cells was induced by miR-429, ** P < 0.01. 
 
 
 
 
Figure 3: Effects of miR-429 overexpression on EMT related proteins expression. 
A: High level of miR-429 increased epithelial marker E-cadherin expression but decreased mesenchy-
mal markers (Vimentin, N-Cadherin, Snail) expression in Saos2 cells, ** P < 0.01 vs control group. B: 
Same changes in U2OS cells as in Saos2 cells, ** P < 0.01 vs control group. 
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ZEB1 is the target gene of miR-429 and 
ZEB1 mRNA expression is inversely related 
to miR-429 expression in OS tissues 
pmirGLO-ZEB1 3’-UTR wt and pmir-
GLO-ZEB1 3’-UTR mut vectors were con-
structed according to the binding site between 
miR-429 and ZEB1 mRNA (Figure 4A). 
HEK 293T cells were cultured and cotrans-
fected with pmirGLO-ZEB1 3’-UTR wt or 
pmirGLO-ZEB1 3’-UTR mut and mimics NC 
or miR-429 mimics or inhibitor NC or miR-
429 inhibitor. The relative luciferase activity 
of reporter with ZEB1 3’-UTR wt was signif-
icantly decreased in cells with miR-429 mim-
ics compared with that in cells with mimics (P 
< 0.01), and that in cells with miR-429 inhib-
itor was obviously increased than that in cells 
with inhibitor NC (P < 0.01). But the relative 
luciferase activity of reporter with ZEB1 3’-
UTR mut had no obvious change among dif-
ferent groups (Figure 4B). Similarly, the rela-
tive expression of ZEB1 mRNA and ZEB1 
protein in OS cells transfected with mimics 
NC or miR-429 inhibitor were both signifi-
cantly higher than that in OS cells transfected 
with miR-429 mimics or inhibitor NC (P < 
0.01) (Figure 4C, D). The correlation analysis 
showed that the relative expression of ZEB1 
mRNA was inversely related to the relative 
expression of miR-429 in OS tissues (R2: 
0.4855, P < 0.01) (Figure 4E). Taken to-
gether, these results indicate that ZEB1 is a 
direct target of miR-429 and miR-429 can 
down-regulate the expression of ZEB1 in OS. 
 
 
Figure 4: Prediction and verification of target gene of miR-429 in osteosarcoma. 
A: The binding site prediction between miR-429 and 3’-UTR region of ZEB1 mRNA. B: Relative lucifer-
ase activity detection, ** P < 0.01. C: ZEB1 mRNA expression in osteosarcoma cells with different treat-
ments, ZEB1 mRNA level was normalized to GAPDH, ** P < 0.01. D: ZEB1 protein expression in oste-
osarcoma cells with different treatments. E: Correlation analysis between ZEB1 relative expression and 
miR-429 relative expression using Pearson’s correlation. 
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DISCUSSION 
miR-429 functions as a tumor suppressor 
and miR-429 level is determined to be de-
creased in many types of cancer (Zhang et al., 
2016). Plenty of miRNAs have been reported 
to function as oncogenes or tumor suppressors 
in OS, like miR-214, miR-183, miR-27a, 
miR-133b, Mir-494, and so on (Ram Kumar 
et al., 2016; Zhi et al., 2016), but there are 
scarcely any researches about mechanism and 
function of miR-429 in OS (Liu et al., 2014). 
So in this study, the miR-429 level in OS tis-
sues and OS cell lines was firstly detected, 
and miR-429 was both down-regulated in OS 
tissues and OS cell lines. Furthermore, overall 
survival analysis suggests that high level of 
miR-429 is associated with favorable progno-
sis. Taken together, miR-429 may function as 
a tumor suppressor in OS. 
Then analyses of OS cells invasion, me-
tastasis, viability and apoptosis indicate that 
up-regulation of miR-429 can effectively sup-
press the invasion, migration and growth abil-
ities of OS cells, but facilitates the apoptosis 
of OS cells in vitro. This consists with the ef-
fects of miR-429 in esophageal carcinoma, 
hepatitis B virus-related hepatocellular carci-
noma, hepatocellular carcinoma (Zhang et al., 
2015). In addition, high level of miR-429 pro-
moted E-cadherin protein expression but in-
hibited the expression of Vimentin, N-Cad-
herin and Snail proteins in OS cells in vitro. 
E-cadherin, an epithelial marker, is a calcium-
dependent cell-cell adhesion glycoprotein, 
down-regulation of E-cadherin will enhance 
the cellular motility leading cancer cells to the 
mesenchymal state and cancer progression 
and metastasis (Polyak and Weinberg, 2009). 
On the contrary, N-Cadherin, another cal-
cium-dependent cell adhesion molecule, is 
normally found in mesenchymal cells and 
cancer cells to play a role in migration 
(Ramis-Conde et al., 2009). Vimentin is the 
major cytoskeletal component of mesenchy-
mal cells, also is a marker of cancer cells un-
dergoing an EMT (Leader et al., 1987). Snail 
is a family of zinc finger transcriptional re-
pressor, can bind to E-cadherin and suppress 
the expression of E-cadherin inducing EMT 
in cancer cells (Kumarswamy et al., 2012). 
EMT is a process in which cells lose intercel-
lular adhesion and obtain migrartory and in-
vasive capabilities. So EMT can enable the 
metastasis and invasion of cancer cells and is 
essential for cancer progression and metasta-
sis (Chaffer and Weinberg, 2011). Thus miR-
429 may play an inhibitory role in multiple 
types of cancer via suppressing cancer cells 
EMT, metastasis, invasion, proliferation and 
promoting cells apoptosis. 
At last, dual luciferase assay and transfec-
tion assay showed ZEB1 was a direct target of 
miR-429 and miR-429 could down-regulate 
the ZEB1 expression both in mRNA level and 
protein level in OS cells. Furthermore, there 
was a negative correlation between miR-429 
expression and ZEB1 mRNA expression in 
OS tissues. ZEB1 is a zinc finger class of tran-
scription factor, which is also an EMT inducer 
and aberrantly expressed in multiple cancers 
(Peinado et al., 2007). Therefore ZEB1 may 
play a similar role in OS tissues and its ex-
pression and functions may be inhibited by tu-
mor suppressor miR-429. 
In summary, miR-429 functions as a tu-
mor suppressor in OS and is down-regulated 
in OS. Overexpression of miR-429 not only 
inhibits the EMT, metastasis, invasion and 
proliferation of OS cells, but also facilitates 
OS cells apoptosis, thus high level of miR-
429 is associated with the favorable prognosis 
of OS. Furthermore, miR-429 can directly 
down-regulate the EMT inducer ZEB1 ex-
pression, so tumor suppressor miR-429 may 
repress the progression and metastasis of OS 
at least partially through inhibiting ZEB1 ex-
pression. 
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